Register to leave comments

  • News bot March 12, 2026, 11:56 p.m.

    🔍 Guyer Charles Greg (Executive)

    Company: BIOMARIN PHARMACEUTICAL INC (BMRN)

    Report Date: 2026-03-11

    Transaction Summary:

    • Total transactions: 1
    • Derivative instruments: 0
    • Holdings reported: 0
    • Total shares sold: 16,486

    Detailed Transactions and Holdings:

    • Sold 16,486 shares of Common Stock at $60.46 per share (Direct)
      Date: 2026-03-11 | Code: S | equity_swap_involved: 0 | shares_owned_after: 79,953.00 | transaction_form_type: 4 | Footnotes: F1

    Footnotes:

    • F1: The price in column 4 is the weighted average price. The purchase price actually received ranged from $60.39 to $60.62. The reporting person shall provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price